|
Volumn 56, Issue 3, 2003, Pages 259-267
|
Studies on novel bacterial translocase I inhibitors, A-500359s. III. Deaminocaprolactam derivatives of capuramycin: A-500359 E, F, H, M-1 and M-2
|
Author keywords
[No Author keywords available]
|
Indexed keywords
A 500359 E;
A 500359 F;
A 500359 H;
A 500359 M 1;
A 500359 M 2;
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ASPARTATE KINASE;
BACTERIAL PROTEIN;
CAPROLACTAM;
CAPURAMYCIN;
CARRIER PROTEIN;
CYSTEINE DERIVATIVE;
DRUG METABOLITE;
TUNICAMYCIN;
UNCLASSIFIED DRUG;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BACTERIUM CULTURE;
CONTROLLED STUDY;
DRUG ACETYLATION;
DRUG HYDROLYSIS;
DRUG ISOLATION;
DRUG PURIFICATION;
DRUG STRUCTURE;
ENZYME INHIBITION;
GROWTH INHIBITION;
IC 50;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM;
NONHUMAN;
PRIORITY JOURNAL;
STRAIN DIFFERENCE;
STREPTOMYCES GRISEUS;
STREPTOMYCES GRISEUS;
|
EID: 0037363273
PISSN: 00218820
EISSN: None
Source Type: Journal
DOI: 10.7164/antibiotics.56.259 Document Type: Article |
Times cited : (34)
|
References (4)
|